Review of the presentation by HJ Schmoll EORTC GI Group. [Preoperative chemoradiotherapy with capecitabine and oxaliplatin vs capecitabine alone in locally advanced rectal cancer: response to the local treatment… read more.
A review of the presentation by Rene Adam MD (pictured). There has been considerable progress in the overall survival of patients with colorectal cancer taking chemotherapy.
A review of the presentation by Sabine Tejpar. The KRAS (codon 12,13) is a validated predictive biomarker in mCRC, it is essential to determine diagnosis and required prior… read more.
A review of the presentation by Volker Heinemann (pictured). The decision on first line treatment in mCRC matters because the number of patients benefitting from therapy diminishes with… read more.
by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.
We ask Professor Heinz-Josef Lenz, Professor of Medicine, Associate Director Clinical Research what he thinks is going to be the next big thing in colorectal cancer for the… read more.
Johns Hopkins researchers see 21-fold increase in a single day. A social media push boosted the number of people who registered themselves as organ donors 21-fold in a… read more.
A review of the presentation by Jaume Capdevila, Barcelona Spain. Unfortunately Neuroendocrine tumours (NETs) are often advanced at the time of diagnosis and the 5 year survival ranges… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to… read more.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
